The Role of Magnesium in Depression, Migraine, Alzheimer's Disease, and Cognitive Health: A Comprehensive Review
- PMID: 40647320
- PMCID: PMC12252419
- DOI: 10.3390/nu17132216
The Role of Magnesium in Depression, Migraine, Alzheimer's Disease, and Cognitive Health: A Comprehensive Review
Abstract
Magnesium is an essential mineral involved in hundreds of biochemical reactions, with particular relevance to maintaining neural homeostasis, modulating neurotransmitter systems, and regulating inflammatory and oxidative stress mechanisms. This comprehensive review aims to evaluate the potential role of magnesium in the pathophysiology and treatment of three prevalent neurological and psychiatric disorders-depression, migraine, and Alzheimer's disease-as well as its broader implications for cognitive health. Current research suggests that magnesium deficiency is associated with the development of depression, as magnesium influences glutamatergic and GABAergic neurotransmission, as well as the activity of the hypothalamic-pituitary-adrenal (HPA) axis, both of which play critical roles in stress responses and mood regulation. Additionally, magnesium's anti-inflammatory properties may contribute to the alleviation of depressive symptoms. In the context of migraine's pathophysiology, magnesium plays a role in regulating cerebral vascular tone, modulating the trigeminovascular system, and reducing neuronal hyperexcitability, which may explain the observed correlation between magnesium levels and the incidence of migraines. Regarding Alzheimer's disease, preclinical and epidemiological studies suggest that magnesium may contribute to modulating neurodegenerative processes and preserving cognitive function; however, due to the heterogeneity of the current findings, further longitudinal and interventional studies are necessary to determine its precise clinical relevance. This review aims to enhance the understanding of the relationship between magnesium and these disorders through a narrative review of relevant clinical studies. The findings may provide insights into the potential therapeutic applications of magnesium and guide the future directions of the research into the prevention and treatment of depression, migraine, and Alzheimer's disease and overall cognitive health.
Keywords: Alzheimer’s disease; HPA axis; cognitive health; depression; inflammation; magnesium; migraine; neurodegeneration; neurotransmitters; oxidative stress.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
References
-
- Danciu C., Antal D., Avram S., Buda V., Pavel I.Z., Minda D., Ardelean F., Nicolov M., Dehelean C. Plant Sources Potential Health Benefits. Nova Science Publishers, Inc.; New York, NY, USA: 2019. Essential mineral elements: Macronutrients and micronutrients from herbs in human health; p. 1.
-
- Kumar A., Mehan S., Tiwari A., Khan Z., Das Gupta G., Narula A.S., Samant R. Magnesium (Mg2+): Essential mineral for neuronal health: From cellular biochemistry to cognitive health and behavior regulation. Curr. Pharm. Des. 2024;30:3074–3107. doi: 10.2174/0113816128321466240816075041. - DOI - PubMed
-
- Schutten J.C., Joris P.J., Minović I., Post A., van Beek A.P., de Borst M.H., Mensink R.P., Bakker S.J.L. Long-term magnesium supplementation improves glucocorticoid metabolism: A post-hoc analysis of an intervention trial. Clin. Endocrinol. 2021;94:150–157. doi: 10.1111/cen.14350. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
